Optical coherence tomography characterization of degradation kinetics between second‐ and third‐generation resorbable magnesium scaffold

The current preclinical study validated OCT indices that may serve as clinical surrogate markers for scaffold degradation. AtI analysis indicated that DREAMS-3G showed less degradation at 6 months but more advanced degradation at 12 months compared to the Magmaris<sup>TM</sup> scaffold, which corroborates the findings from planimetric analysis.

Authors

Institutions

Publication Details

Journal
Catheterization and Cardiovascular Interventions
Published
2024-09-23
DOI
https://doi.org/10.1002/ccd.31238
Citations
1
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optical coherence tomography characterization of degradation kinetics between second‐ and third‐generation resorbable magnesium scaffold

Martin Pritsch, Masaru Seguchi, Philipp Nicol, Alp Aytekin et al.
1 citations
Catheterization and Cardiovascular Interventions
Coronary Interventions and Diagnostics
0.57
article

Optical coherence tomography characterization of degradation kinetics between second‐ and third‐generation resorbable magnesium scaffold

Martin Pritsch, Masaru Seguchi, Philipp Nicol, Alp Aytekin, Jonas Altevogt, Michael Joner, Philine Baumann‐Zumstein, Armin Fubel
article en
1 citations

Abstract

The current preclinical study validated OCT indices that may serve as clinical surrogate markers for scaffold degradation. AtI analysis indicated that DREAMS-3G showed less degradation at 6 months but more advanced degradation at 12 months compared to the Magmaris<sup>TM</sup> scaffold, which corroborates the findings from planimetric analysis.

Catheterization and Cardiovascular InterventionsVol. 104(5)
Jichi Medical University (JP), German Centre for Cardiovascular Research (DE), Deutsches Herzzentrum München (DE), Jichi Medical University Saitama Medical Center (JP), Biotronik (Switzerland) (CH)
Biotronik
Openalex Percentile: Top 30%
Coronary Interventions and Diagnostics
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.